# Bone health and fracture risk in diabetes: A multicenter study

**Authors:** Özen Öz Gül, Zeynep Cantürk, Sadettin Öztürk, Nilüfer Özdemir, Dilek Kılınç Candemir, Burak Özbaş, Filiz Mercantepe, Filiz Mercan Sarıdaş, Erhan Hocaoğlu, Onur Elbasan, Burcu Candemir, Berrin Çetinarslan, Ali Saklamaz, Şerife Ezgi Doğan, Elif Seray Korkmaz, Sezin Doğan Çakır, Hülya Kaynak, Emine Kartal Baykan, Mehmet Güven, Murat Çalapkulu, Onur Daloğlu, Yasemin Aydoğan Ünsal, Özlem Kanburoğlu, Selin Çakmak Demir, Dilek Gogas Yavuz, Zeynep Çetin, Ayşen Akkurt Kocaeli, Zeliha Hekimsoy, Mithat Mızrak, Zehra Candan, Erman Çakal, Gülce Ecem Kılıç, Göknur Yorulmaz, Mine Adaş, Zeliha Yarar, Pınar Akhanlı, Metin Güçlü, Muhammet Cüneyt Bilginer, Adnan Batman, Sevdenur Taşkın, Sema Hepşen, Aysen Akalın, Serpil Çiftel, Anna Abbasgholizadeh, Oğuzhan Deyneli, Zehra Erdemir, Gamze Gelir Çavdar, Yusuf Kayhan, Taner Bayraktaroğlu, Güven Özkaya

PMC · DOI: 10.1007/s11657-026-01667-z · 2026-02-16

## TL;DR

A study of over 2500 diabetic patients in Türkiye found that type 1 diabetes is linked to lower bone density while type 2 diabetes is associated with higher fracture risk despite stronger bones.

## Contribution

The study reveals distinct bone health patterns in T1DM and T2DM patients through a large multicenter analysis in Türkiye.

## Key findings

- T1DM patients had significantly lower bone mineral density at all skeletal sites.
- T2DM patients showed higher fracture risk despite higher bone mineral density.
- Modifiable factors like low BMI and reduced SGLT2 inhibitor use predicted osteoporosis.

## Abstract

We assessed bone health in over 2500 adults with diabetes across Türkiye. T1DM patients had lower BMD, while T2DM patients showed higher fracture risk despite higher BMD. Several modifiable factors were linked to osteoporosis. These findings support personalized bone assessments in diabetic populations.

Diabetes mellitus (DM) is a recognized risk factor for bone fragility. While type 1 DM (T1DM) is typically associated with low bone mineral density (BMD), type 2 DM (T2DM) often presents with higher BMD despite increased fracture risk. Large-scale comparative studies remain limited.

To evaluate bone health, including osteopenia, osteoporosis, and fracture risk, in adults with T1DM and T2DM.

This multicenter, cross-sectional study included 2562 patients (224 with T1DM, 2338 with T2DM) from 27 centers across Türkiye. BMD was assessed using dual-energy X-ray absorptiometry (DXA) and fracture risk was estimated via the Turkish-adapted FRAX® algorithm in patients aged ≥ 40 years. Multinomial logistic regression was used to identify independent predictors of low BMD.

Osteoporosis prevalence was 5.5% in T1DM and 9.6% in T2DM (femoral neck T-score). Adjusted BMD was significantly lower in T1DM at all skeletal sites, while FRAX-based fracture risk and fall-related fractures were higher in T2DM. Independent predictors of osteoporosis included older age, female sex, lower BMI, reduced calcium levels, corticosteroid use, albuminuria, hypertension, and less frequent sodium-glucose cotransporter-2 (SGLT2) inhibitor use. T1DM was independently associated with osteopenia but not osteoporosis.

This multicenter study demonstrates distinct patterns of BMD and fracture risk across diabetes subtypes and supports individualized bone health assessment in routine diabetes care.

## Linked entities

- **Diseases:** diabetes mellitus (MONDO:0005015), osteoporosis (MONDO:0005298)

## Full-text entities

- **Genes:** SLC5A2 (solute carrier family 5 member 2) [NCBI Gene 6524] {aka SGLT2}, SLC17A5 (solute carrier family 17 member 5) [NCBI Gene 26503] {aka AST, ISSD, NSD, SD, SIALIN, SIASD}, PTH (parathyroid hormone) [NCBI Gene 5741] {aka FIH1, PTH1}, GPT (glutamic--pyruvic transaminase) [NCBI Gene 2875] {aka AAT1, ALT, ALT1, GPT1, SGPT}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}
- **Diseases:** neuropathy (MESH:D009422), impaired calcium absorption (MESH:C564600), peripheral arterial disease (MESH:D058729), Type 1 and Type 2 Diabetes Mellitus (MESH:D003924), nephropathy (MESH:D007674), skeletal deterioration (OMIM:616592), impaired postural control (MESH:D007174), peripheral neuropathy (MESH:D010523), T1DM (MESH:D003922), coronary artery disease (MESH:D003324), diabetic microvascular complications (OMIM:603933), diabetic retinopathy (MESH:D003930), ischemic heart disease (MESH:D017202), cerebrovascular disease (MESH:D002561), bone loss (MESH:D001847), insulin deficiency (MESH:D007333), Osteoporosis (MESH:D010024), albuminuria (MESH:D000419), diabetic complications (MESH:D048909), Hypertension (MESH:D006973), hip fracture (MESH:D006620), metabolic (MESH:D008659), skeletal fragility (MESH:D005600), bone formation (MESH:D058426), bone fragility (MESH:C536063), BMD (MESH:D001851), bone resorption (MESH:D001862), diabetic microangiopathy (MESH:D003925), vitamin D insufficiency (MESH:D014808), overweight (MESH:D050177), Retinopathy (MESH:D058437), stroke (MESH:D020521), reduced bone turnover (MESH:D001523), malignancy (MESH:D009369), DM (MESH:D003920), endothelial dysfunction (MESH:D014652), polyneuropathy (MESH:D011115), osteoporotic (MESH:D058866), secondary hyperparathyroidism (MESH:D006962), inflammation (MESH:D007249), hyperglycemia (MESH:D006943), Fracture (MESH:D050723)
- **Chemicals:** alcohol (MESH:D000438), magnesium (MESH:D008274), glucose (MESH:D005947), creatinine (MESH:D003404), calcium (MESH:D002118), TZDs (MESH:D045162), lipid (MESH:D008055), 25 (OH) vitamin D (-), 25-hydroxyvitamin D (MESH:C104450), AGEs (MESH:D017127), canagliflozin (MESH:D000068896), TZD (MESH:C089946), vitamin D (MESH:D014807), phosphorus (MESH:D010758)
- **Species:** Homo sapiens (human, species) [taxon 9606], Nicotiana tabacum (American tobacco, species) [taxon 4097]
- **Mutations:** A1C

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12909314/full.md

---
Source: https://tomesphere.com/paper/PMC12909314